Ajay K. Gopal

Also affiliated with Fred Hutch Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 19 papers. Top paper: “Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study”.

Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study

The Lancet Haematology(2021)10.1016/s2352-3026(21)00170-8

N/A

1.6DataRank · unranked

59 citations

Ryan D. Cassaday, Stephen D. Smith, Jonathan R. Fromm, Andrew J. Cowan, Edus H. Warren +15 more

Concurrent pembrolizumab with AVD for untreated classical Hodgkin lymphoma

Blood(2023)10.1182/blood.2022019254

N/A

1.4DataRank · unranked

39 citations

Chaitra S. Ujjani, Christina Poh, Edus H. Warren, Stephen D. Smith, Mazyar Shadman +21 more

Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL

Blood(2022)10.1182/blood.2021014497

N/A

0.601DataRank · unranked

54 citations

Nicolas Gazeau, Alexandre V. Hirayama, Joshua A. Hill, Vicky Wu, Aisling Cearley +17 more

Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient

Cancer Cell(2021)10.1016/j.ccell.2021.06.015

N/A

0.489DataRank · unranked

25 citations

Chaitra S. Ujjani, Alexander L. Greninger, Mazyar Shadman, Ajay K. Gopal, Joshua A. Hill

Hypertension treatment for patients receiving ibrutinib: a multicenter retrospective study

Blood Advances(2024)10.1182/bloodadvances.2023011569

N/A

0.373DataRank · unranked

11 citations

Jenna Voutsinas, Bita Fakhri, Sirin Khajavian, Stephen E. Spurgeon, Deborah M. Stephens +30 more

A phase II trial evaluating the efficacy of high‐dose Radioiodinated Tositumomab (Anti‐CD20) antibody, etoposide and cyclophosphamide followed by autologous transplantation, for high‐risk relapsed or refractory non‐hodgkin lymphoma

American Journal of Hematology(2020)10.1002/ajh.25818

N/A

0.360DataRank · unranked

10 citations

Joseph G. Rajendran, Darrell R. Fisher, Frederick R. Appelbaum, Ryan D. Cassaday, Paul S. Martin +8 more

Development and validation of predictive models of early immune effector cell–associated hematotoxicity

Blood Advances(2024)10.1182/bloodadvances.2024014455

N/A

0.360DataRank · unranked

10 citations

Jennifer J. Huang, Andrew J. Portuguese, Valentín Ortiz‐Maldonado, Aya Albittar, Natalie Wuliji +28 more

Assessment of Left Ventricular, Right Ventricular, and Left Atrial Strain in Light-Chain Amyloidosis

JACC CardioOncology(2020)10.1016/j.jaccao.2020.09.002

N/A

0.241DataRank · unranked

4 citations

Alexi Vasbinder, Hans Huang, Robin Fernandes, Andrew J. Cowan, Ajay K. Gopal +4 more

Efficacy, safety, and molecular response predictors of oral ixazomib and short-course rituximab in untreated iNHL

Blood Advances(2022)10.1182/bloodadvances.2022008628

N/A

0.240DataRank · unranked

3 citations

Ryan C. Lynch, Chaitra S. Ujjani, Ted Gooley, Heather Rasmussen, David G. Coffey +9 more

A “FUNCTIONAL CURE” MAY BE ACHIEVABLE IN A SUBSET OF PATIENTS WITH FOLLICULAR LYMPHOMA TREATED WITH CHEMOIMMUNOTHERAPY: 15‐YEAR FOLLOW‐UP OF PHASE III SWOG‐S0016

Hematological Oncology(2023)10.1002/hon.3163_79

N/A

0.165DataRank · unranked

2 citations

H. Li, Lisa M. Rimsza, John P. Leonard, Mark Kaminski, Catherine Spier +6 more

A multiplexed assay for quantifying immunomodulatory proteins supports correlative studies in immunotherapy clinical trials

Frontiers in Oncology(2023)10.3389/fonc.2023.1168710

N/A

0DataRank · unranked

5 citations

Lei Zhao, Regine M. Schoenherr, Dongqing Huang, Rachel A. Lundeen, Ulianna Voytovich +24 more

Long-term efficacy and safety of pembrolizumab with R-CHOP as first-line therapy for DLBCL.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.7561

N/A

0DataRank · unranked

1 citations

Jonathan R. Fromm, Min Fang, Brian G. Till, Mazyar Shadman, Andrew J. Cowan +11 more

The impact of histological grade on outcomes in follicular lymphoma: An analysis of patients in the SEER database in the context of evolving disease classification and treatment

British Journal of Haematology(2022)10.1111/bjh.18404

N/A

0DataRank · unranked

18 citations

Ted Gooley, Keith R. Loeb, Lorinda Soma, Stephen D. Smith, Ajay K. Gopal +2 more

CD46 and CD59 inhibitors enhance complement-dependent cytotoxicity of anti-CD38 monoclonal antibodies daratumumab and isatuximab in multiple myeloma and other B-cell malignancy cells

Cancer Biology & Therapy(2024)10.1080/15384047.2024.2314322

N/A

0DataRank · unranked

12 citations

Theo Koob, Jonathan R. Fromm, Ajay K. Gopal, Darrick Carter, Andre Lieber +1 more

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

UNC Libraries(2020)10.17615/w76e-ms81

N/A

0DataRank · unranked

0 citations

Amanda Axtman, Mark D. Hylarides, Jaideep Shenoi, Shani M. Frayo, Steven I. Park +11 more

A phase 2 study of frontline pembrolizumab in follicular lymphoma

eJHaem(2024)10.1002/jha2.1029

N/A

0DataRank · unranked

0 citations

Songli Zhu, Ted Gooley, Taranjit S. Gujral, Ryan C. Lynch, Christina Poh +5 more

CD19 directed CAR T therapy for intravascular large B-cell lymphoma

Haematologica(2025)10.3324/haematol.2025.288838

N/A

0DataRank · unranked

1 citations

Ajay K. Gopal, Hannah Cherniawsky, Ron Ram, Rammurti T. Kamble, Mehdi Hamadani +1 more

Pembrolizumab With R-CHOP in Previously Untreated DLBCL: Sustained, High Efficacy, and Safety With Long-Term Follow-Up

Clinical Lymphoma Myeloma & Leukemia(2023)10.1016/j.clml.2023.10.002

N/A

0DataRank · unranked

12 citations

Ajay K. Gopal, Brian G. Till, Mazyar Shadman, Ryan C. Lynch, Andrew J. Cowan +10 more

Diffuse large B-cell lymphoma (DLBCL) is infiltrated with activated CD8 + T-cells despite immune checkpoint signaling

Blood Research(2022)10.5045/br.2022.2021145

N/A

0DataRank · unranked

13 citations

Jonathan R. Fromm, Ajay K. Gopal, A. McGarry Houghton, Adam Greenbaum